Literature DB >> 17706845

Metaanalysis of vaccine effectiveness in varicella outbreaks.

Otmar Bayer1, Ulrich Heininger, Cora Heiligensetzer, Rüdiger von Kries.   

Abstract

There is a number of reports on varicella outbreaks in populations where a one dose varicella immunization program has been implemented. We performed a metaanalysis to provide a summary vaccine effectiveness (VE) estimate and to assess the possible impact of waning immunity by means of a subgroup analysis by time since immunization. We found a VE of 72.5% (95% CI 68.5-76.0) derived from 3157 children in 14 publications. Immunization coverage of the respective population was unrelated to VE. All studies (n=4) that allowed the computation of VE over time since immunization showed a substantial decrease. In total, waning immunity was assessed by nine studies. Two reported no relation between VE and time since immunization without specifying how this had been assessed. Seven studies calculated relative risks for contracting varicella after prolonged as compared to a shorter period since immunization and reported an increased relative risk for prolonged periods. In conclusion, this metaanalysis confirms a limited effectiveness of one dose of varicella vaccine and points to waning immunity as an important causal factor. Waning might also be an issue with the newly recommended two dose vaccination schedule. Sustained surveillance for varicella outbreaks in populations with varicella immunization programs therefore is mandatory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706845     DOI: 10.1016/j.vaccine.2007.07.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

2.  Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Alexia Campbell; Shainoor Ismail; Ben Tan
Journal:  Can Commun Dis Rep       Date:  2010-10-18

3.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

Review 4.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

Review 5.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

6.  Varicella: efficacy of two-dose vaccination in childhood.

Authors:  Peter Wutzler; Markus Knuf; Johannes Liese
Journal:  Dtsch Arztebl Int       Date:  2008-08-15       Impact factor: 5.594

7.  Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Authors:  Johannes Horn; André Karch; Oliver Damm; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; Hartmut Hengel; Wolfgang Greiner; Rafael T Mikolajczyk
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

Review 8.  Chickenpox.

Authors:  Judith Breuer; Helen Fifer
Journal:  BMJ Clin Evid       Date:  2011-04-11

Review 9.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

10.  Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Hum Exp Toxicol       Date:  2013-11-25       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.